With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...

Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on ...

The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...

Four years ago, high school senior Aaron O’Brien wouldn’t believe he’d be studying chemistry now. Thanks to the Upward Bound program, that’s not hard to believe anymore. “Before I came into the ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The ghost in Joko Anwar‘s “Ghost in the Cell” doesn’t haunt – it holds accountable. Indonesian filmmaker Anwar used his Berlinale Forum entry “Ghost in the Cell” to channel societal anxieties about ...

Out Of Order is a Java-based interactive game designed to test and improve the player's cognitive abilities. In this game, players are presented with a sequence of characters or numbers that are out ...

Zepbound (tirzepatide) and Mounjaro (tirzepatide) are prescription drugs used to treat different conditions. Zepbound and Mounjaro are not available as generic drugs. The two drugs have some ...

When it comes to antinausea drugs, insurance company coverage restrictions are common and vary widely by insurance, drug, and location, a new analysis has revealed. Overall, researchers found that ...

If you’ve ever wondered, even briefly, whether you have obesity, you might want to double-check right about now. New research suggests that over two-thirds of Americans are considered obese under ...

Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the ...